Biological drug development for novel biospecific drugs
Immunocore develops innovative biological therapeutics that use the power of the body’s own immune system to find and eradicate diseased cells. With the foundation’s support, the company is expanding its focus into infectious disease.
- Focus areas
- Life Sciences
- Investment type
- Direct equity
- Status
- Active
- Initial investment
- Series B
- Partnered in
- 2017
- Headquarters
- United Kingdom
More about our work
Our focus
We embrace science and technology innovations that solve old problems in new ways, challenge status quos, and build on past breakthroughs. Our six domains of focus comprise 40+ program strategies across the foundation’s nearly $9B annual charitable support.
Investment Approach
How the Strategic Investment Fund is fostering partnerships with the private sector to leverage the globe’s most groundbreaking global innovations for societal good.
Our Team
The SIF Investment Committee brings depth of experience to global investment programs, with a proven track record of innovation across sectors and scale.